Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

IVD industry loses battle for 5-yr EU IVD Reg transition: where does Council position lie?

This article was originally published in Clinica

Executive Summary

The IVD industry was dealt a disappointing blow by the European Parliament yesterday (22 October) when the top item on its wish list – to be given five years, instead of three, to transition to the new proposed IVD Regulation – was rejected during the plenary vote. This means that the IVD industry must ensure that each and every one of its products complies with the new regulations within three years following adoption of the IVD Regulation. In many cases this will also involve an audit – often for the first time for companies’ products – by a notified body to demonstrate compliance with EU regulatory requirements.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT101004

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel